img

Global Veterinary Anti-Infectives Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Veterinary Anti-Infectives Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Europe and Asia Pacific are growing regions in this market, but North America is the most lucrative among the other regions. This can be attributed to an increase in pet ownership and soaring demand for improved nutrition, especially animal protein. Widened focus on food safety also contributes to the higher demand.
Due to the COVID-19 pandemic, the global Veterinary Anti-Infectives market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Marbofloxacin accounting for % of the Veterinary Anti-Infectives global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Companion Animals segment is altered to an % CAGR throughout this forecast period.
The fast growth in the Asia Pacific (APAC) region can be attributed to trends such as promotion of small animal care, the livestock segment fueling the market for veterinary therapeutics, and key players focusing on distribution partnerships in India.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Veterinary Anti-Infectives market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Veterinary Anti-Infectives market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Veterinary Anti-Infectives market. Readers of the report can become informed about current and future trends of the global Veterinary Anti-Infectives market and how they will impact market growth during the forecast period.



By Company


Zoetis Animal Healthcare
Merck
Merial (Sanofi)
Elanco
Bayer Healthcare
Ceva Animal Health
Virbac
Boehringer Ingelheim
Segment by Type
Marbofloxacin
Florfenicol
Freeze-dried Ceftiofur
Beta-lactams
Oxytetracycline
Aminosidine

Segment by Application


Companion Animals
Farm Animals
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Veterinary Anti-Infectives in global and regional level.
Chapter 3Detailed analysis of Veterinary Anti-Infectives companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Anti-Infectives revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Anti-Infectives Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Marbofloxacin
1.2.3 Florfenicol
1.2.4 Freeze-dried Ceftiofur
1.2.5 Beta-lactams
1.2.6 Oxytetracycline
1.2.7 Aminosidine
1.3 Market by Application
1.3.1 Global Veterinary Anti-Infectives Market Growth Rate by Application: 2018 VS 2024 VS 2034
1.3.2 Companion Animals
1.3.3 Farm Animals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Veterinary Anti-Infectives Market Size (2018-2034)
2.2 Veterinary Anti-Infectives Market Size across Key Geographies Worldwide: 2018 VS 2024 VS 2034
2.3 Global Veterinary Anti-Infectives Market Size by Region (2018-2023)
2.4 Global Veterinary Anti-Infectives Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Veterinary Anti-Infectives Countries Ranking by Market Size
3 Veterinary Anti-Infectives Competitive by Company
3.1 Global Veterinary Anti-Infectives Revenue by Players
3.1.1 Global Veterinary Anti-Infectives Revenue by Players (2018-2023)
3.1.2 Global Veterinary Anti-Infectives Market Share by Players (2018-2023)
3.2 Global Veterinary Anti-Infectives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Veterinary Anti-Infectives Revenue
3.4 Global Veterinary Anti-Infectives Market Concentration Ratio
3.4.1 Global Veterinary Anti-Infectives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Anti-Infectives Revenue in 2024
3.5 Global Key Players of Veterinary Anti-Infectives Head office and Area Served
3.6 Global Key Players of Veterinary Anti-Infectives, Product and Application
3.7 Global Key Players of Veterinary Anti-Infectives, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Veterinary Anti-Infectives Breakdown Data by Type
4.1 Global Veterinary Anti-Infectives Historic Revenue by Type (2018-2023)
4.2 Global Veterinary Anti-Infectives Forecasted Revenue by Type (2024-2034)
5 Global Veterinary Anti-Infectives Breakdown Data by Application
5.1 Global Veterinary Anti-Infectives Historic Market Size by Application (2018-2023)
5.2 Global Veterinary Anti-Infectives Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Veterinary Anti-Infectives Revenue by Company (2021-2023)
6.2 North America Veterinary Anti-Infectives Revenue by Type (2018-2034)
6.3 North America Veterinary Anti-Infectives Revenue by Application (2018-2034)
6.4 North America Veterinary Anti-Infectives Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Veterinary Anti-Infectives Revenue by Company (2021-2023)
7.2 Europe Veterinary Anti-Infectives Revenue by Type (2018-2034)
7.3 Europe Veterinary Anti-Infectives Revenue by Application (2018-2034)
7.4 Europe Veterinary Anti-Infectives Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Veterinary Anti-Infectives Revenue by Company (2021-2023)
8.2 Asia Pacific Veterinary Anti-Infectives Revenue by Type (2018-2034)
8.3 Asia Pacific Veterinary Anti-Infectives Revenue by Application (2018-2034)
8.4 Asia Pacific Veterinary Anti-Infectives Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Veterinary Anti-Infectives Revenue by Company (2021-2023)
9.2 Latin America Veterinary Anti-Infectives Revenue by Type (2018-2034)
9.3 Latin America Veterinary Anti-Infectives Revenue by Application (2018-2034)
9.4 Latin America Veterinary Anti-Infectives Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Veterinary Anti-Infectives Revenue by Company (2021-2023)
10.2 Middle East and Africa Veterinary Anti-Infectives Revenue by Type (2018-2034)
10.3 Middle East and Africa Veterinary Anti-Infectives Revenue by Application (2018-2034)
10.4 Middle East and Africa Veterinary Anti-Infectives Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Zoetis Animal Healthcare
11.1.1 Zoetis Animal Healthcare Company Details
11.1.2 Zoetis Animal Healthcare Business Overview
11.1.3 Zoetis Animal Healthcare Veterinary Anti-Infectives Products and Services
11.1.4 Zoetis Animal Healthcare Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023)
11.1.5 Zoetis Animal Healthcare Veterinary Anti-Infectives SWOT Analysis
11.1.6 Zoetis Animal Healthcare Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Veterinary Anti-Infectives Products and Services
11.2.4 Merck Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023)
11.2.5 Merck Veterinary Anti-Infectives SWOT Analysis
11.2.6 Merck Recent Development
11.3 Merial (Sanofi)
11.3.1 Merial (Sanofi) Company Details
11.3.2 Merial (Sanofi) Business Overview
11.3.3 Merial (Sanofi) Veterinary Anti-Infectives Products and Services
11.3.4 Merial (Sanofi) Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023)
11.3.5 Merial (Sanofi) Veterinary Anti-Infectives SWOT Analysis
11.3.6 Merial (Sanofi) Recent Development
11.4 Elanco
11.4.1 Elanco Company Details
11.4.2 Elanco Business Overview
11.4.3 Elanco Veterinary Anti-Infectives Products and Services
11.4.4 Elanco Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023)
11.4.5 Elanco Veterinary Anti-Infectives SWOT Analysis
11.4.6 Elanco Recent Development
11.5 Bayer Healthcare
11.5.1 Bayer Healthcare Company Details
11.5.2 Bayer Healthcare Business Overview
11.5.3 Bayer Healthcare Veterinary Anti-Infectives Products and Services
11.5.4 Bayer Healthcare Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023)
11.5.5 Bayer Healthcare Veterinary Anti-Infectives SWOT Analysis
11.5.6 Bayer Healthcare Recent Development
11.6 Ceva Animal Health
11.6.1 Ceva Animal Health Company Details
11.6.2 Ceva Animal Health Business Overview
11.6.3 Ceva Animal Health Veterinary Anti-Infectives Products and Services
11.6.4 Ceva Animal Health Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023)
11.6.5 Ceva Animal Health Veterinary Anti-Infectives SWOT Analysis
11.6.6 Ceva Animal Health Recent Development
11.7 Virbac
11.7.1 Virbac Company Details
11.7.2 Virbac Business Overview
11.7.3 Virbac Veterinary Anti-Infectives Products and Services
11.7.4 Virbac Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023)
11.7.5 Virbac Veterinary Anti-Infectives SWOT Analysis
11.7.6 Virbac Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Veterinary Anti-Infectives Products and Services
11.8.4 Boehringer Ingelheim Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023)
11.8.5 Boehringer Ingelheim Veterinary Anti-Infectives SWOT Analysis
11.8.6 Boehringer Ingelheim Recent Development
12 Veterinary Anti-Infectives Market Dynamics
12.1 Veterinary Anti-Infectives Industry Trends
12.2 Veterinary Anti-Infectives Market Drivers
12.3 Veterinary Anti-Infectives Market Challenges
12.4 Veterinary Anti-Infectives Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Veterinary Anti-Infectives Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of Marbofloxacin
Table 3. Key Players of Florfenicol
Table 4. Key Players of Freeze-dried Ceftiofur
Table 5. Key Players of Beta-lactams
Table 6. Key Players of Oxytetracycline
Table 7. Key Players of Aminosidine
Table 8. Global Veterinary Anti-Infectives Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 9. Global Veterinary Anti-Infectives Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
Table 10. Global Veterinary Anti-Infectives Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Veterinary Anti-Infectives Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 12. Global Veterinary Anti-Infectives Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Table 13. Global Veterinary Anti-Infectives Revenue by Players (2018-2023) & (US$ Million)
Table 14. Global Veterinary Anti-Infectives Market Share by Players (2018-2023)
Table 15. Global Top Veterinary Anti-Infectives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Anti-Infectives as of 2024)
Table 16. Ranking of Global Top Veterinary Anti-Infectives Companies by Revenue (US$ Million) in 2024
Table 17. Global 5 Largest Players Market Share by Veterinary Anti-Infectives Revenue (CR5 and HHI) & (2018-2023)
Table 18. Global Key Players of Veterinary Anti-Infectives, Headquarters and Area Served
Table 19. Global Key Players of Veterinary Anti-Infectives, Product and Application
Table 20. Global Key Players of Veterinary Anti-Infectives, Date of Enter into This Industry
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Veterinary Anti-Infectives Market Size by Type (2018-2023) & (US$ Million)
Table 23. Global Veterinary Anti-Infectives Revenue Market Share by Type (2018-2023)
Table 24. Global Veterinary Anti-Infectives Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 25. Global Veterinary Anti-Infectives Revenue Market Share by Type (2024-2034)
Table 26. Global Veterinary Anti-Infectives Market Size by Application (2018-2023) & (US$ Million)
Table 27. Global Veterinary Anti-Infectives Revenue Market Share by Application (2018-2023)
Table 28. Global Veterinary Anti-Infectives Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 29. Global Veterinary Anti-Infectives Revenue Market Share by Application (2024-2034)
Table 30. North America Veterinary Anti-Infectives Revenue by Company (2021-2023) & (US$ Million)
Table 31. North America Veterinary Anti-Infectives Revenue by Type (2018-2023) & (US$ Million)
Table 32. North America Veterinary Anti-Infectives Revenue by Type (2024-2034) & (US$ Million)
Table 33. North America Veterinary Anti-Infectives Revenue by Application (2018-2023) & (US$ Million)
Table 34. North America Veterinary Anti-Infectives Revenue by Application (2024-2034) & (US$ Million)
Table 35. North America Veterinary Anti-Infectives Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. North America Veterinary Anti-Infectives Revenue by Country (2018-2023) & (US$ Million)
Table 37. North America Veterinary Anti-Infectives Revenue by Country (2024-2034) & (US$ Million)
Table 38. Europe Veterinary Anti-Infectives Revenue by Company (2021-2023) & (US$ Million)
Table 39. Europe Veterinary Anti-Infectives Revenue by Type (2018-2023) & (US$ Million)
Table 40. Europe Veterinary Anti-Infectives Revenue by Type (2024-2034) & (US$ Million)
Table 41. Europe Veterinary Anti-Infectives Revenue by Application (2018-2023) & (US$ Million)
Table 42. Europe Veterinary Anti-Infectives Revenue by Application (2024-2034) & (US$ Million)
Table 43. Europe Veterinary Anti-Infectives Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Europe Veterinary Anti-Infectives Revenue by Country (2018-2023) & (US$ Million)
Table 45. Europe Veterinary Anti-Infectives Revenue by Country (2024-2034) & (US$ Million)
Table 46. Asia Pacific Veterinary Anti-Infectives Revenue by Company (2021-2023) & (US$ Million)
Table 47. Asia Pacific Veterinary Anti-Infectives Revenue by Type (2018-2023) & (US$ Million)
Table 48. Asia Pacific Veterinary Anti-Infectives Revenue by Type (2024-2034) & (US$ Million)
Table 49. Asia Pacific Veterinary Anti-Infectives Revenue by Application (2018-2023) & (US$ Million)
Table 50. Asia Pacific Veterinary Anti-Infectives Revenue by Application (2024-2034) & (US$ Million)
Table 51. Asia-Pacific Veterinary Anti-Infectives Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 52. Asia Pacific Veterinary Anti-Infectives Revenue by Region (2018-2023) & (US$ Million)
Table 53. Asia Pacific Veterinary Anti-Infectives Revenue by Region (2024-2034) & (US$ Million)
Table 54. Latin America Veterinary Anti-Infectives Revenue by Company (2021-2023) & (US$ Million)
Table 55. Latin America Veterinary Anti-Infectives Revenue by Type (2018-2023) & (US$ Million)
Table 56. Latin America Veterinary Anti-Infectives Revenue by Type (2024-2034) & (US$ Million)
Table 57. Latin America Veterinary Anti-Infectives Revenue by Application (2018-2023) & (US$ Million)
Table 58. Latin America Veterinary Anti-Infectives Revenue by Application (2024-2034) & (US$ Million)
Table 59. Latin America Veterinary Anti-Infectives Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 60. Latin America Veterinary Anti-Infectives Revenue by Country (2018-2023) & (US$ Million)
Table 61. Latin America Veterinary Anti-Infectives Revenue by Country (2024-2034) & (US$ Million)
Table 62. Middle East and Africa Veterinary Anti-Infectives Revenue by Company (2021-2023) & (US$ Million)
Table 63. Middle East and Africa Veterinary Anti-Infectives Revenue by Type (2018-2023) & (US$ Million)
Table 64. Middle East and Africa Veterinary Anti-Infectives Revenue by Type (2024-2034) & (US$ Million)
Table 65. Middle East and Africa Veterinary Anti-Infectives Revenue by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Veterinary Anti-Infectives Revenue by Application (2024-2034) & (US$ Million)
Table 67. Middle East and Africa Veterinary Anti-Infectives Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 68. Middle East and Africa Veterinary Anti-Infectives Revenue by Country (2018-2023) & (US$ Million)
Table 69. Middle East and Africa Veterinary Anti-Infectives Revenue by Country (2024-2034) & (US$ Million)
Table 70. Zoetis Animal Healthcare Company Details
Table 71. Zoetis Animal Healthcare Business Overview
Table 72. Zoetis Animal Healthcare Veterinary Anti-Infectives Product and Services
Table 73. Zoetis Animal Healthcare Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023) & (US$ Million)
Table 74. Zoetis Animal Healthcare Veterinary Anti-Infectives SWOT Analysis
Table 75. Zoetis Animal Healthcare Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Veterinary Anti-Infectives Product and Services
Table 79. Merck Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023) & (US$ Million)
Table 80. Merck Veterinary Anti-Infectives SWOT Analysis
Table 81. Merck Recent Development
Table 82. Merial (Sanofi) Company Details
Table 83. Merial (Sanofi) Business Overview
Table 84. Merial (Sanofi) Veterinary Anti-Infectives Product and Services
Table 85. Merial (Sanofi) Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023) & (US$ Million)
Table 86. Merial (Sanofi) Veterinary Anti-Infectives SWOT Analysis
Table 87. Merial (Sanofi) Recent Development
Table 88. Elanco Company Details
Table 89. Elanco Business Overview
Table 90. Elanco Veterinary Anti-Infectives Product and Services
Table 91. Elanco Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023) & (US$ Million)
Table 92. Elanco Veterinary Anti-Infectives SWOT Analysis
Table 93. Elanco Recent Development
Table 94. Bayer Healthcare Company Details
Table 95. Bayer Healthcare Business Overview
Table 96. Bayer Healthcare Veterinary Anti-Infectives Product and Services
Table 97. Bayer Healthcare Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023) & (US$ Million)
Table 98. Bayer Healthcare Veterinary Anti-Infectives SWOT Analysis
Table 99. Bayer Healthcare Recent Development
Table 100. Ceva Animal Health Company Details
Table 101. Ceva Animal Health Business Overview
Table 102. Ceva Animal Health Veterinary Anti-Infectives Product and Services
Table 103. Ceva Animal Health Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023) & (US$ Million)
Table 104. Ceva Animal Health Veterinary Anti-Infectives SWOT Analysis
Table 105. Ceva Animal Health Recent Development
Table 106. Virbac Company Details
Table 107. Virbac Business Overview
Table 108. Virbac Veterinary Anti-Infectives Product and Services
Table 109. Virbac Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023) & (US$ Million)
Table 110. Virbac Veterinary Anti-Infectives SWOT Analysis
Table 111. Virbac Recent Development
Table 112. Boehringer Ingelheim Company Details
Table 113. Boehringer Ingelheim Business Overview
Table 114. Boehringer Ingelheim Veterinary Anti-Infectives Product and Services
Table 115. Boehringer Ingelheim Veterinary Anti-Infectives Revenue in Veterinary Anti-Infectives Business (2018-2023) & (US$ Million)
Table 116. Boehringer Ingelheim Veterinary Anti-Infectives SWOT Analysis
Table 117. Boehringer Ingelheim Recent Development
Table 118. Veterinary Anti-Infectives Market Trends
Table 119. Veterinary Anti-Infectives Market Drivers
Table 120. Veterinary Anti-Infectives Market Challenges
Table 121. Veterinary Anti-Infectives Market Restraints
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Anti-Infectives Product Picture
Figure 2. Global Veterinary Anti-Infectives Market Size by Type (US$ Million): 2018 VS 2024 VS 2034
Figure 3. Global Veterinary Anti-Infectives Market Share by Type: 2024 VS 2034
Figure 4. Marbofloxacin Features
Figure 5. Florfenicol Features
Figure 6. Freeze-dried Ceftiofur Features
Figure 7. Beta-lactams Features
Figure 8. Oxytetracycline Features
Figure 9. Aminosidine Features
Figure 10. Global Veterinary Anti-Infectives Market Size by Application (US$ Million): 2018 VS 2024 VS 2034
Figure 11. Global Veterinary Anti-Infectives Market Share by Application: 2024 VS 2034
Figure 12. Companion Animals
Figure 13. Farm Animals
Figure 14. Others
Figure 15. Veterinary Anti-Infectives Report Years Considered
Figure 16. Global Veterinary Anti-Infectives Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Veterinary Anti-Infectives Market Size 2018-2034 (US$ Million)
Figure 18. Global Veterinary Anti-Infectives Market Size Market Share by Region: 2024 VS 2034
Figure 19. Global Veterinary Anti-Infectives Revenue Market Share by Region in 2018 VS 2024
Figure 20. Global Veterinary Anti-Infectives Revenue Market Share Forecast by Region (2024-2034)
Figure 21. Global Top 10 Veterinary Anti-Infectives Countries Ranking by Market Size (US$ Million) in 2024
Figure 22. Global Veterinary Anti-Infectives Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Figure 23. Global Veterinary Anti-Infectives Market Share by Players in 2024
Figure 24. Global Top Veterinary Anti-Infectives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Anti-Infectives as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by Veterinary Anti-Infectives Revenue in 2024
Figure 26. North America Veterinary Anti-Infectives Revenue Market Share by Company in 2024
Figure 27. North America Veterinary Anti-Infectives Revenue Market Share by Type (2018-2034)
Figure 28. North America Veterinary Anti-Infectives Revenue Market Share by Application (2018-2034)
Figure 29. North America Veterinary Anti-Infectives Revenue Share by Country (2018-2034)
Figure 30. U.S. Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 31. Canada Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 32. Europe Veterinary Anti-Infectives Revenue Market Share by Company in 2024
Figure 33. Europe Veterinary Anti-Infectives Revenue Market Share by Type (2018-2034)
Figure 34. Europe Veterinary Anti-Infectives Revenue Market Share by Application (2018-2034)
Figure 35. Europe Veterinary Anti-Infectives Revenue Share by Country (2018-2034)
Figure 36. Germany Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 37. France Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 38. U.K. Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 39. Italy Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 40. Russia Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 41. Asia Pacific Veterinary Anti-Infectives Revenue Market Share by Company in 2024
Figure 42. Asia Pacific Veterinary Anti-Infectives Revenue Market Share by Type (2018-2034)
Figure 43. Asia Pacific Veterinary Anti-Infectives Revenue Market Share by Application (2018-2034)
Figure 44. Asia Pacific Veterinary Anti-Infectives Revenue Share by Region (2018-2034)
Figure 45. China Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 46. Japan Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 47. South Korea Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 48. India Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 49. Australia Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 50. Taiwan Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 51. Indonesia Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 52. Thailand Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 53. Malaysia Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 54. Philippines Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 55. Vietnam Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 56. Latin America Veterinary Anti-Infectives Revenue Market Share by Company in 2024
Figure 57. Latin America Veterinary Anti-Infectives Revenue Market Share by Type (2018-2034)
Figure 58. Latin America Veterinary Anti-Infectives Revenue Market Share by Application (2018-2034)
Figure 59. Latin America Veterinary Anti-Infectives Revenue Share by Country (2018-2034)
Figure 60. Mexico Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 61. Brazil Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 62. Argentina Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 63. Middle East and Africa Veterinary Anti-Infectives Revenue Market Share by Company in 2024
Figure 64. Middle East and Africa Veterinary Anti-Infectives Revenue Market Share by Type (2018-2034)
Figure 65. Middle East and Africa Veterinary Anti-Infectives Revenue Market Share by Application (2018-2034)
Figure 66. Middle East and Africa Veterinary Anti-Infectives Revenue Share by Country (2018-2034)
Figure 67. Turkey Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 68. Saudi Arabia Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 69. UAE Veterinary Anti-Infectives Revenue (2018-2034) & (US$ Million)
Figure 70. Zoetis Animal Healthcare Revenue Growth Rate in Veterinary Anti-Infectives Business (2018-2023)
Figure 71. Merck Revenue Growth Rate in Veterinary Anti-Infectives Business (2018-2023)
Figure 72. Merial (Sanofi) Revenue Growth Rate in Veterinary Anti-Infectives Business (2018-2023)
Figure 73. Elanco Revenue Growth Rate in Veterinary Anti-Infectives Business (2018-2023)
Figure 74. Bayer Healthcare Revenue Growth Rate in Veterinary Anti-Infectives Business (2018-2023)
Figure 75. Ceva Animal Health Revenue Growth Rate in Veterinary Anti-Infectives Business (2018-2023)
Figure 76. Virbac Revenue Growth Rate in Veterinary Anti-Infectives Business (2018-2023)
Figure 77. Boehringer Ingelheim Revenue Growth Rate in Veterinary Anti-Infectives Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed